| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroimaging | 6 | 2024 | 402 | 2.050 |
Why?
|
| Glioma | 8 | 2024 | 1978 | 1.820 |
Why?
|
| Axonal Transport | 3 | 2020 | 40 | 1.500 |
Why?
|
| Molecular Imaging | 7 | 2016 | 186 | 1.460 |
Why?
|
| Magnetic Resonance Imaging | 31 | 2024 | 7895 | 1.450 |
Why?
|
| Brain Neoplasms | 13 | 2024 | 4958 | 1.410 |
Why?
|
| Machine Learning | 4 | 2022 | 363 | 1.400 |
Why?
|
| Intracranial Thrombosis | 3 | 2017 | 19 | 1.090 |
Why?
|
| Brain Ischemia | 9 | 2023 | 311 | 0.920 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2024 | 585 | 0.910 |
Why?
|
| Stroke | 13 | 2023 | 1058 | 0.890 |
Why?
|
| X-Ray Microtomography | 4 | 2020 | 136 | 0.810 |
Why?
|
| Tomography, X-Ray Computed | 15 | 2021 | 7784 | 0.790 |
Why?
|
| White Matter | 5 | 2024 | 188 | 0.780 |
Why?
|
| Four-Dimensional Computed Tomography | 3 | 2020 | 231 | 0.760 |
Why?
|
| Brain | 11 | 2019 | 4213 | 0.710 |
Why?
|
| Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2019 | 13 | 0.680 |
Why?
|
| Neoplasm Grading | 3 | 2024 | 1822 | 0.680 |
Why?
|
| Parathyroid Neoplasms | 4 | 2022 | 190 | 0.680 |
Why?
|
| Image-Guided Biopsy | 2 | 2020 | 336 | 0.680 |
Why?
|
| Thyroid Gland | 2 | 2020 | 366 | 0.640 |
Why?
|
| Image Processing, Computer-Assisted | 10 | 2022 | 1689 | 0.630 |
Why?
|
| Tetanus Toxin | 3 | 2020 | 36 | 0.630 |
Why?
|
| Retinal Diseases | 1 | 2020 | 190 | 0.590 |
Why?
|
| Genetic Therapy | 5 | 2006 | 1714 | 0.560 |
Why?
|
| Ki-67 Antigen | 1 | 2019 | 676 | 0.560 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 4 | 2019 | 57 | 0.560 |
Why?
|
| Glycolysis | 1 | 2019 | 530 | 0.540 |
Why?
|
| Retina | 1 | 2020 | 539 | 0.540 |
Why?
|
| Histiocytosis, Sinus | 3 | 2020 | 86 | 0.540 |
Why?
|
| Adenoma | 3 | 2022 | 740 | 0.520 |
Why?
|
| Diagnostic Imaging | 5 | 2023 | 1174 | 0.520 |
Why?
|
| Thromboembolism | 1 | 2016 | 150 | 0.510 |
Why?
|
| Calcium | 1 | 2021 | 1589 | 0.490 |
Why?
|
| Cerebral Infarction | 5 | 2023 | 72 | 0.480 |
Why?
|
| Genetic Vectors | 4 | 2006 | 1857 | 0.480 |
Why?
|
| Thyroid Neoplasms | 3 | 2022 | 1884 | 0.470 |
Why?
|
| Fluorescent Dyes | 4 | 2012 | 469 | 0.440 |
Why?
|
| Radionuclide Imaging | 4 | 2015 | 655 | 0.440 |
Why?
|
| Viruses | 2 | 2006 | 156 | 0.440 |
Why?
|
| Brain Diseases | 2 | 2008 | 412 | 0.410 |
Why?
|
| Matrix Metalloproteinase 2 | 4 | 2020 | 258 | 0.410 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 3 | 2018 | 334 | 0.410 |
Why?
|
| Spinal Diseases | 3 | 2011 | 131 | 0.400 |
Why?
|
| Algorithms | 4 | 2024 | 3900 | 0.390 |
Why?
|
| Matrix Metalloproteinase 9 | 4 | 2020 | 350 | 0.390 |
Why?
|
| Brain Infarction | 1 | 2011 | 36 | 0.390 |
Why?
|
| Infarction, Middle Cerebral Artery | 4 | 2019 | 43 | 0.380 |
Why?
|
| Contrast Media | 6 | 2019 | 1499 | 0.380 |
Why?
|
| Neurons | 3 | 2012 | 2454 | 0.370 |
Why?
|
| Spinal Cord Injuries | 1 | 2014 | 349 | 0.370 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2017 | 382 | 0.370 |
Why?
|
| Pyruvic Acid | 3 | 2019 | 132 | 0.370 |
Why?
|
| Animals | 36 | 2023 | 62048 | 0.350 |
Why?
|
| Stem Cell Transplantation | 3 | 2006 | 1414 | 0.340 |
Why?
|
| Plaque, Atherosclerotic | 4 | 2020 | 153 | 0.340 |
Why?
|
| Intracranial Hemorrhages | 4 | 2019 | 120 | 0.340 |
Why?
|
| Organoplatinum Compounds | 1 | 2012 | 704 | 0.340 |
Why?
|
| Microscopy, Confocal | 2 | 2009 | 659 | 0.340 |
Why?
|
| Carotid Artery Thrombosis | 2 | 2020 | 9 | 0.320 |
Why?
|
| Brain Stem Neoplasms | 1 | 2009 | 100 | 0.320 |
Why?
|
| Neurilemmoma | 1 | 2009 | 134 | 0.320 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2012 | 409 | 0.310 |
Why?
|
| Cerebrovascular Circulation | 2 | 2011 | 514 | 0.310 |
Why?
|
| Leukoaraiosis | 2 | 2019 | 6 | 0.310 |
Why?
|
| Disease Models, Animal | 11 | 2020 | 7383 | 0.310 |
Why?
|
| Positron-Emission Tomography | 3 | 2011 | 2196 | 0.310 |
Why?
|
| Iodine | 2 | 2019 | 55 | 0.310 |
Why?
|
| Male | 44 | 2024 | 128400 | 0.300 |
Why?
|
| Aged | 34 | 2024 | 73383 | 0.300 |
Why?
|
| Peptide Fragments | 2 | 2012 | 1309 | 0.300 |
Why?
|
| Thrombosis | 3 | 2023 | 743 | 0.300 |
Why?
|
| Spheroids, Cellular | 1 | 2008 | 220 | 0.300 |
Why?
|
| Middle Aged | 33 | 2024 | 90348 | 0.290 |
Why?
|
| Fibrinolytic Agents | 2 | 2021 | 293 | 0.280 |
Why?
|
| Mice | 25 | 2023 | 35597 | 0.280 |
Why?
|
| Luminescent Measurements | 2 | 2006 | 158 | 0.280 |
Why?
|
| Radiopharmaceuticals | 6 | 2018 | 1341 | 0.280 |
Why?
|
| Cell Transplantation | 1 | 2006 | 87 | 0.280 |
Why?
|
| Radiation Injuries | 1 | 2014 | 1470 | 0.270 |
Why?
|
| Basal Ganglia | 1 | 2006 | 62 | 0.270 |
Why?
|
| Phantoms, Imaging | 6 | 2019 | 1330 | 0.270 |
Why?
|
| Humans | 60 | 2024 | 270806 | 0.270 |
Why?
|
| Female | 41 | 2024 | 148969 | 0.260 |
Why?
|
| Radiographic Image Enhancement | 2 | 2019 | 410 | 0.260 |
Why?
|
| Carotid Artery Diseases | 2 | 2020 | 176 | 0.260 |
Why?
|
| Aged, 80 and over | 19 | 2024 | 31009 | 0.250 |
Why?
|
| Cathepsin B | 4 | 2013 | 35 | 0.240 |
Why?
|
| Spinal Cord | 3 | 2014 | 720 | 0.240 |
Why?
|
| Adult | 18 | 2024 | 81998 | 0.230 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 4375 | 0.220 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2020 | 10385 | 0.220 |
Why?
|
| Gene Transfer Techniques | 2 | 2004 | 804 | 0.220 |
Why?
|
| Aspirin | 3 | 2021 | 374 | 0.220 |
Why?
|
| Exercise Therapy | 2 | 2020 | 293 | 0.220 |
Why?
|
| Graft Survival | 1 | 2006 | 1082 | 0.210 |
Why?
|
| ROC Curve | 2 | 2020 | 1250 | 0.210 |
Why?
|
| Calcinosis | 2 | 2017 | 426 | 0.210 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 661 | 0.200 |
Why?
|
| Heptanoic Acids | 3 | 2013 | 89 | 0.200 |
Why?
|
| Teaching Materials | 1 | 2002 | 23 | 0.200 |
Why?
|
| Photosensitizing Agents | 2 | 2013 | 82 | 0.200 |
Why?
|
| Adoptive Transfer | 1 | 2004 | 431 | 0.200 |
Why?
|
| Radiology Information Systems | 1 | 2003 | 119 | 0.200 |
Why?
|
| Simplexvirus | 2 | 2002 | 180 | 0.200 |
Why?
|
| Mice, Inbred BALB C | 3 | 2014 | 2455 | 0.190 |
Why?
|
| Multidetector Computed Tomography | 2 | 2022 | 147 | 0.190 |
Why?
|
| Cyclobutanes | 1 | 2021 | 36 | 0.190 |
Why?
|
| Prospective Studies | 7 | 2024 | 13417 | 0.190 |
Why?
|
| Carboxylic Acids | 1 | 2021 | 57 | 0.190 |
Why?
|
| Herpesvirus 1, Human | 2 | 2004 | 115 | 0.190 |
Why?
|
| Deprescriptions | 1 | 2020 | 25 | 0.190 |
Why?
|
| Logistic Models | 3 | 2020 | 3448 | 0.190 |
Why?
|
| Dabigatran | 1 | 2020 | 27 | 0.190 |
Why?
|
| World Health Organization | 1 | 2022 | 327 | 0.190 |
Why?
|
| Clinical Decision-Making | 1 | 2024 | 532 | 0.180 |
Why?
|
| Antithrombins | 1 | 2020 | 62 | 0.180 |
Why?
|
| Rats, Inbred BN | 1 | 2020 | 36 | 0.180 |
Why?
|
| Thrombin | 2 | 2020 | 91 | 0.180 |
Why?
|
| Thrombophilia | 1 | 2020 | 55 | 0.180 |
Why?
|
| Whole Body Imaging | 2 | 2012 | 120 | 0.180 |
Why?
|
| Platelet Aggregation | 1 | 2020 | 182 | 0.180 |
Why?
|
| N-Methylaspartate | 1 | 2020 | 53 | 0.180 |
Why?
|
| Proteins | 1 | 2008 | 2043 | 0.170 |
Why?
|
| Infarction, Anterior Cerebral Artery | 1 | 2019 | 3 | 0.170 |
Why?
|
| Infarction, Posterior Cerebral Artery | 1 | 2019 | 2 | 0.170 |
Why?
|
| Carotid Artery, Common | 1 | 2020 | 93 | 0.170 |
Why?
|
| Software | 3 | 2019 | 1356 | 0.170 |
Why?
|
| Mice, Nude | 4 | 2019 | 4329 | 0.170 |
Why?
|
| Incidental Findings | 1 | 2021 | 282 | 0.170 |
Why?
|
| Endocytosis | 1 | 2020 | 233 | 0.160 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2019 | 14 | 0.160 |
Why?
|
| Stroke, Lacunar | 1 | 2018 | 1 | 0.160 |
Why?
|
| Retrospective Studies | 13 | 2023 | 39834 | 0.160 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2020 | 256 | 0.160 |
Why?
|
| Cerebral Arteries | 1 | 2019 | 100 | 0.160 |
Why?
|
| Atlases as Topic | 1 | 2019 | 45 | 0.160 |
Why?
|
| Blood-Brain Barrier | 2 | 2014 | 251 | 0.160 |
Why?
|
| Cerebrum | 1 | 2019 | 40 | 0.160 |
Why?
|
| Microscopy, Fluorescence | 3 | 2009 | 768 | 0.160 |
Why?
|
| Indium Radioisotopes | 1 | 1998 | 63 | 0.160 |
Why?
|
| Pyrroles | 3 | 2013 | 589 | 0.160 |
Why?
|
| Retinal Ganglion Cells | 1 | 2020 | 162 | 0.160 |
Why?
|
| Gadolinium DTPA | 2 | 2016 | 173 | 0.160 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2017 | 161 | 0.150 |
Why?
|
| Fluorine Radioisotopes | 1 | 2019 | 139 | 0.150 |
Why?
|
| Meningioma | 1 | 2021 | 308 | 0.150 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2018 | 7 | 0.150 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2021 | 880 | 0.150 |
Why?
|
| Lipids | 3 | 2020 | 654 | 0.150 |
Why?
|
| Gold | 3 | 2017 | 267 | 0.150 |
Why?
|
| Brain Mapping | 2 | 2019 | 625 | 0.150 |
Why?
|
| Ventricular Pressure | 1 | 2018 | 44 | 0.150 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 2 | 2010 | 45 | 0.150 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2019 | 149 | 0.150 |
Why?
|
| Lymphocytes | 1 | 2023 | 1275 | 0.150 |
Why?
|
| Herpes Simplex | 1 | 1998 | 100 | 0.150 |
Why?
|
| Virion | 1 | 1998 | 186 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2020 | 908 | 0.140 |
Why?
|
| Radiography | 1 | 2002 | 1988 | 0.140 |
Why?
|
| Intracranial Embolism | 1 | 2017 | 40 | 0.140 |
Why?
|
| Gene Expression | 2 | 2002 | 3642 | 0.140 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 427 | 0.140 |
Why?
|
| Meningeal Neoplasms | 1 | 2021 | 473 | 0.140 |
Why?
|
| Axons | 1 | 2020 | 441 | 0.140 |
Why?
|
| Drug Monitoring | 1 | 2019 | 352 | 0.140 |
Why?
|
| Hemorrhage | 1 | 2021 | 727 | 0.140 |
Why?
|
| Physical Conditioning, Animal | 1 | 2017 | 115 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2016 | 116 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 3845 | 0.130 |
Why?
|
| Synapses | 1 | 2020 | 556 | 0.130 |
Why?
|
| Atherosclerosis | 3 | 2021 | 912 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 6 | 2017 | 7103 | 0.130 |
Why?
|
| Carbon Radioisotopes | 1 | 2015 | 124 | 0.130 |
Why?
|
| Gadolinium | 1 | 2016 | 169 | 0.130 |
Why?
|
| Apolipoproteins E | 5 | 2017 | 220 | 0.130 |
Why?
|
| Hyperparathyroidism, Primary | 2 | 2018 | 142 | 0.130 |
Why?
|
| Optical Imaging | 1 | 2017 | 158 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2019 | 2363 | 0.130 |
Why?
|
| Luciferases | 3 | 2006 | 460 | 0.120 |
Why?
|
| Metal Nanoparticles | 1 | 2017 | 161 | 0.120 |
Why?
|
| Photochemotherapy | 2 | 2013 | 116 | 0.120 |
Why?
|
| Porphyrins | 2 | 2013 | 39 | 0.120 |
Why?
|
| Fibrin | 1 | 2015 | 82 | 0.120 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 5171 | 0.120 |
Why?
|
| Thoracic Vertebrae | 2 | 2012 | 200 | 0.120 |
Why?
|
| Young Adult | 5 | 2020 | 22226 | 0.120 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 564 | 0.120 |
Why?
|
| Luminescent Proteins | 2 | 2008 | 300 | 0.120 |
Why?
|
| Parathyroid Glands | 2 | 2012 | 127 | 0.110 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 478 | 0.110 |
Why?
|
| Cytokines | 3 | 2020 | 2826 | 0.110 |
Why?
|
| Brain Edema | 1 | 2014 | 96 | 0.110 |
Why?
|
| Genes, Reporter | 2 | 2008 | 820 | 0.110 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 965 | 0.110 |
Why?
|
| Medulloblastoma | 1 | 2019 | 572 | 0.110 |
Why?
|
| Renal Artery Obstruction | 1 | 2013 | 40 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2013 | 14616 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2008 | 693 | 0.110 |
Why?
|
| Image Enhancement | 1 | 2016 | 553 | 0.110 |
Why?
|
| Carotid Arteries | 2 | 2013 | 250 | 0.100 |
Why?
|
| Biomarkers | 2 | 2023 | 5060 | 0.100 |
Why?
|
| Republic of Korea | 2 | 2024 | 76 | 0.100 |
Why?
|
| Anticholesteremic Agents | 2 | 2013 | 249 | 0.100 |
Why?
|
| Polylysine | 1 | 2011 | 19 | 0.100 |
Why?
|
| Nanoparticles | 2 | 2015 | 585 | 0.100 |
Why?
|
| Lactic Acid | 1 | 2013 | 310 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 517 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 5759 | 0.100 |
Why?
|
| Niacinamide | 1 | 2013 | 428 | 0.100 |
Why?
|
| Ticlopidine | 1 | 2011 | 49 | 0.100 |
Why?
|
| Triiodobenzoic Acids | 1 | 2011 | 69 | 0.090 |
Why?
|
| Reproducibility of Results | 5 | 2024 | 6193 | 0.090 |
Why?
|
| Biological Transport | 1 | 2012 | 627 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 607 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 730 | 0.090 |
Why?
|
| Quinolinium Compounds | 1 | 2009 | 4 | 0.090 |
Why?
|
| Endothelium | 1 | 2010 | 156 | 0.090 |
Why?
|
| Glucosamine | 1 | 2009 | 27 | 0.090 |
Why?
|
| Lymphatic System | 1 | 2009 | 55 | 0.090 |
Why?
|
| Phenylurea Compounds | 1 | 2013 | 600 | 0.080 |
Why?
|
| Prognosis | 3 | 2024 | 22481 | 0.080 |
Why?
|
| Diet | 1 | 2017 | 1480 | 0.080 |
Why?
|
| Sciatic Nerve | 1 | 2009 | 120 | 0.080 |
Why?
|
| Kidney | 2 | 2013 | 2121 | 0.080 |
Why?
|
| Vascular Neoplasms | 1 | 2010 | 112 | 0.080 |
Why?
|
| Injections, Intramuscular | 1 | 2009 | 247 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 986 | 0.080 |
Why?
|
| Luminescent Agents | 1 | 2008 | 18 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2024 | 4140 | 0.080 |
Why?
|
| Aortic Diseases | 1 | 2011 | 196 | 0.080 |
Why?
|
| Stem Cells | 2 | 2006 | 1217 | 0.080 |
Why?
|
| Carotid Stenosis | 1 | 2010 | 159 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2020 | 218 | 0.080 |
Why?
|
| Treatment Outcome | 7 | 2024 | 33741 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 262 | 0.080 |
Why?
|
| Neoplasms | 3 | 2015 | 15920 | 0.070 |
Why?
|
| Craniotomy | 1 | 2009 | 304 | 0.070 |
Why?
|
| Rats | 3 | 2002 | 6525 | 0.070 |
Why?
|
| Computed Tomography Angiography | 2 | 2020 | 247 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 654 | 0.070 |
Why?
|
| Spleen | 2 | 2000 | 726 | 0.070 |
Why?
|
| Models, Animal | 2 | 2016 | 657 | 0.070 |
Why?
|
| Aorta | 1 | 2011 | 670 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2019 | 339 | 0.070 |
Why?
|
| Linear Models | 1 | 2009 | 1097 | 0.070 |
Why?
|
| Mice, Knockout | 5 | 2017 | 5731 | 0.070 |
Why?
|
| Cell Movement | 2 | 2004 | 2472 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 396 | 0.070 |
Why?
|
| Hyperparathyroidism | 1 | 2006 | 101 | 0.070 |
Why?
|
| Factor XIII | 1 | 2005 | 9 | 0.060 |
Why?
|
| Injections, Intravenous | 2 | 2013 | 591 | 0.060 |
Why?
|
| Parathyroidectomy | 1 | 2006 | 211 | 0.060 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2005 | 55 | 0.060 |
Why?
|
| Radiosurgery | 1 | 2014 | 1383 | 0.060 |
Why?
|
| Paresis | 1 | 2004 | 54 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 5860 | 0.060 |
Why?
|
| Adiponectin | 2 | 2017 | 143 | 0.060 |
Why?
|
| Technetium Tc 99m Sestamibi | 2 | 2018 | 125 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2004 | 274 | 0.060 |
Why?
|
| Registries | 1 | 2011 | 2209 | 0.060 |
Why?
|
| Time Factors | 5 | 2020 | 13021 | 0.060 |
Why?
|
| Radionuclide Angiography | 1 | 2002 | 5 | 0.050 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 2002 | 17 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2023 | 233 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2004 | 445 | 0.050 |
Why?
|
| Gamma Cameras | 1 | 2002 | 39 | 0.050 |
Why?
|
| Isotope Labeling | 1 | 2002 | 149 | 0.050 |
Why?
|
| Data Accuracy | 1 | 2022 | 45 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 823 | 0.050 |
Why?
|
| Microspheres | 1 | 2002 | 238 | 0.050 |
Why?
|
| Medical History Taking | 1 | 2002 | 175 | 0.050 |
Why?
|
| Carcinoma | 1 | 2013 | 2609 | 0.050 |
Why?
|
| Leukocyte Count | 1 | 2023 | 735 | 0.050 |
Why?
|
| Noxae | 1 | 2020 | 1 | 0.050 |
Why?
|
| Mean Platelet Volume | 1 | 2020 | 5 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 3215 | 0.050 |
Why?
|
| Observer Variation | 1 | 2003 | 709 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2020 | 120 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2019 | 7237 | 0.050 |
Why?
|
| Rivaroxaban | 1 | 2020 | 58 | 0.040 |
Why?
|
| Chlorides | 1 | 2020 | 129 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2000 | 239 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2023 | 427 | 0.040 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2020 | 7 | 0.040 |
Why?
|
| Ferric Compounds | 1 | 2020 | 77 | 0.040 |
Why?
|
| Injections, Intralesional | 1 | 2000 | 169 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2006 | 3045 | 0.040 |
Why?
|
| Factor Xa Inhibitors | 1 | 2020 | 71 | 0.040 |
Why?
|
| Running | 1 | 2020 | 43 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2010 | 1776 | 0.040 |
Why?
|
| Brachytherapy | 1 | 2006 | 1005 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 10706 | 0.040 |
Why?
|
| Platelet Count | 1 | 2020 | 492 | 0.040 |
Why?
|
| Liver | 2 | 2000 | 3089 | 0.040 |
Why?
|
| Polyethylenes | 1 | 1999 | 14 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2002 | 606 | 0.040 |
Why?
|
| Equipment Design | 1 | 2002 | 1209 | 0.040 |
Why?
|
| Tracheal Stenosis | 1 | 1999 | 42 | 0.040 |
Why?
|
| Lung | 2 | 2000 | 3300 | 0.040 |
Why?
|
| Muscle Neoplasms | 1 | 1999 | 108 | 0.040 |
Why?
|
| Cell Line | 3 | 2013 | 5339 | 0.040 |
Why?
|
| Pyridones | 1 | 2020 | 360 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 326 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2006 | 2376 | 0.040 |
Why?
|
| Kinetics | 2 | 2015 | 2221 | 0.040 |
Why?
|
| Resistin | 1 | 2017 | 42 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 2212 | 0.040 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 148 | 0.040 |
Why?
|
| Tetrazolium Salts | 1 | 2017 | 49 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2017 | 124 | 0.040 |
Why?
|
| Fluoresceins | 1 | 2017 | 74 | 0.040 |
Why?
|
| Echocardiography, Doppler | 1 | 2018 | 187 | 0.040 |
Why?
|
| Support Vector Machine | 1 | 2017 | 41 | 0.040 |
Why?
|
| Intra-Abdominal Fat | 1 | 2017 | 94 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 4831 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 1999 | 294 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 14838 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1998 | 929 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 897 | 0.030 |
Why?
|
| Apolipoprotein A-I | 1 | 2016 | 95 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2017 | 233 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2017 | 708 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2016 | 138 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2018 | 269 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2016 | 721 | 0.030 |
Why?
|
| Lymphoma, T-Cell | 1 | 1999 | 366 | 0.030 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1999 | 278 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2024 | 2027 | 0.030 |
Why?
|
| Lymph Nodes | 2 | 2020 | 3078 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 1313 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 1825 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 362 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2020 | 1260 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 2848 | 0.030 |
Why?
|
| Lithium Chloride | 1 | 2013 | 29 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 4480 | 0.030 |
Why?
|
| Chlorophyllides | 1 | 2013 | 3 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 2392 | 0.030 |
Why?
|
| Ligation | 1 | 2013 | 206 | 0.030 |
Why?
|
| Erythema | 1 | 2013 | 48 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 7665 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2014 | 453 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 2311 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 558 | 0.030 |
Why?
|
| Atrophy | 1 | 2013 | 271 | 0.030 |
Why?
|
| Chitosan | 1 | 2013 | 85 | 0.030 |
Why?
|
| Carbon Isotopes | 1 | 2013 | 364 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 5924 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2020 | 1544 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 1292 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 741 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2010 | 1933 | 0.020 |
Why?
|
| Echo-Planar Imaging | 1 | 2011 | 74 | 0.020 |
Why?
|
| Adolescent | 4 | 2020 | 32744 | 0.020 |
Why?
|
| Salivary Gland Diseases | 1 | 2011 | 11 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2015 | 799 | 0.020 |
Why?
|
| Pituitary Diseases | 1 | 2011 | 19 | 0.020 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2011 | 33 | 0.020 |
Why?
|
| Meninges | 1 | 2011 | 50 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2011 | 61 | 0.020 |
Why?
|
| Infrared Rays | 1 | 2011 | 62 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 1134 | 0.020 |
Why?
|
| Recurrence | 1 | 2019 | 4877 | 0.020 |
Why?
|
| Drug Eruptions | 1 | 2013 | 271 | 0.020 |
Why?
|
| Mediastinal Diseases | 1 | 2011 | 59 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 4328 | 0.020 |
Why?
|
| Light | 1 | 2011 | 279 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2014 | 728 | 0.020 |
Why?
|
| Corpus Callosum | 1 | 2010 | 127 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2011 | 247 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 164 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3919 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2010 | 167 | 0.020 |
Why?
|
| Microscopy | 1 | 2011 | 189 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6255 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2013 | 566 | 0.020 |
Why?
|
| Reoperation | 1 | 2014 | 1392 | 0.020 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2011 | 144 | 0.020 |
Why?
|
| Leptin | 1 | 2011 | 306 | 0.020 |
Why?
|
| Endarterectomy, Carotid | 1 | 2010 | 99 | 0.020 |
Why?
|
| Fluorescence | 1 | 2009 | 198 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 5828 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 4963 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2010 | 565 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 4498 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 1372 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1999 | 1738 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 9290 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2011 | 366 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2011 | 360 | 0.020 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2010 | 604 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 2320 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2011 | 1271 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 1311 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2010 | 987 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 2091 | 0.020 |
Why?
|
| Macrophages | 1 | 2011 | 1352 | 0.020 |
Why?
|
| Child | 2 | 2020 | 30547 | 0.020 |
Why?
|
| Apoptosis | 1 | 2019 | 7754 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2011 | 2251 | 0.010 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2004 | 46 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 2004 | 125 | 0.010 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2004 | 58 | 0.010 |
Why?
|
| Lac Operon | 1 | 2004 | 133 | 0.010 |
Why?
|
| Stents | 1 | 2010 | 999 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1999 | 5676 | 0.010 |
Why?
|
| Injections | 1 | 2004 | 286 | 0.010 |
Why?
|
| Heparin | 1 | 2005 | 342 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2004 | 824 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 17901 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2006 | 1567 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 6855 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2005 | 775 | 0.010 |
Why?
|
| Empyema | 1 | 1999 | 37 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2004 | 760 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 3483 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2004 | 955 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 15213 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 17049 | 0.010 |
Why?
|
| Pneumonectomy | 1 | 1999 | 862 | 0.010 |
Why?
|
| Survival Rate | 1 | 2006 | 12527 | 0.010 |
Why?
|
| Quality of Life | 1 | 2006 | 4775 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 5569 | 0.000 |
Why?
|